Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283910
Max Phase: Preclinical
Molecular Formula: C55H95N5O15
Molecular Weight: 1066.38
Associated Items:
ID: ALA5283910
Max Phase: Preclinical
Molecular Formula: C55H95N5O15
Molecular Weight: 1066.38
Associated Items:
Canonical SMILES: CCCCC[C@@H]1OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C1=O
Standard InChI: InChI=1S/C55H95N5O15/c1-16-21-26-31-41-46(61)56(11)37(7)52(67)72-43(33-28-23-18-3)48(63)58(13)39(9)54(69)74-45(35-30-25-20-5)50(65)60(15)40(10)55(70)75-44(34-29-24-19-4)49(64)59(14)38(8)53(68)73-42(32-27-22-17-2)47(62)57(12)36(6)51(66)71-41/h36-45H,16-35H2,1-15H3/t36-,37-,38-,39-,40-,41+,42+,43+,44+,45+/m1/s1
Standard InChI Key: LXXQZAAILPIHSY-XQZCZENMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1066.38 | Molecular Weight (Monoisotopic): 1065.6825 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Smith AN, Blackwell DJ, Knollmann BC, Johnston JN.. (2021) Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity., 12 (12.0): [PMID:34917258] [10.1021/acsmedchemlett.1c00508] |
Source(1):